<- Go Home

iCAD, Inc.

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy.

Market Cap

EUR 41.9M

Volume

442.9K

Cash and Equivalents

EUR 20.4M

EBITDA

-EUR 4.7M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 16.4M

Profit Margin

87.08%

52 Week High

EUR 2.65

52 Week Low

EUR 1.18

Dividend

N/A

Price / Book Value

1.35

Price / Earnings

-9.16

Price / Tangible Book Value

1.86

Enterprise Value

EUR 22.0M

Enterprise Value / EBITDA

-4.80

Operating Income

-EUR 5.1M

Return on Equity

-14.86%

Return on Assets

-7.67

Cash and Short Term Investments

EUR 20.4M

Debt

EUR 469.0K

Equity

EUR 31.0M

Revenue

EUR 18.8M

Unlevered FCF

-EUR 2.9M

Sector

Health Care Technology

Category

N/A

Company Stock Pitches